Undecimal Bio raises $19M Seed
Undecimal Bio: Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its proprietary AI-enabled platform f
- Round
- Seed
- Amount
- $19M (€16M)
- Announced
- Lead investors
- Not disclosed
- Headquarters
Source (found by the agent, not yet verified)
More: Undecimal Bio funding history · rounds in October 2026 · rounds in unknown country